Company intelligence / Profile preview

Bionativa

Barberino Tavarnelle (Sambuca VP), Tuscany, Italy

Ownership: Private
Employees: ~99
Development stage: Other

Overview

Bionativa offers CE/FDA/GMP/ISO-certified medical devices, cosmetics, and supplements with global distribution. Clinical results are product-specific, with claims for improved wound repair, ocular comfort, mucosal health, and skin DNA protection; products are in clinical use, not investigational.

Therapeutic areas: Women's HealthOphthalmologyDermatologyRheumatology
Modalities: Medical deviceSmall moleculeBiologicNutraceuticalCosmetic formulation
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with healthcare professionalsPharmacistsHerbalistsPartnerships with universities/research centers (not named)

Beyond the preview

Go deeper on Bionativa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionativa.

Explore the full profile